Abstract
Study design:
Postal questionnaire survey.
Objective:
To examine the current use of hormone replacement therapy (HRT) in a sample of menopausal women with spinal cord injury (SCI).
Setting:
National Spinal Injuries Centre (NSIC), Stoke Mandeville Hospital, Aylesbury, UK.
Method:
A postal questionnaire was sent to 94 women from the NSIC patient database who met the study inclusion criteria (wheelchair dependent, aged 49 years and above, last seen or heard from within the last 3 years).
Results:
A total of 59 valid questionnaires were analysed. At the time of the survey, 50 women were menopausal and 11 of them were using HRT, six for menopausal symptoms and five for osteoporosis prevention. Another 11 had used HRT, eight for menopausal symptoms and three for osteoporosis prevention, but had discontinued it. The main reasons for stopping HRT were side effects. Of the 28 women who had never been on HRT, 20 had either enquired about it, or had been offered HRT, but decided against it. Of the nine women who were still premenopausal at the time of the survey, four would consider using HRT.
Conclusions:
Results show that 44% of the menopausal women in our sample have used HRT at some point and 22% still do, mostly for treatment of menopausal symptoms and for osteoporosis prevention. In view of the latest literature findings in able-bodied women, use of HRT for osteoporosis prevention in women with SCI may have to be reconsidered.
Sponsorship:
Partly supported by the Stoke Mandeville Hospital Charitable Fund.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Cochrane HRT Study Group. Hormone replacement therapy for perimenopausal and postmenopausal women (Protocol for a Cochrane Review). In: The Cochrane Library, Issue 1. John Wiley & Sons, Ltd.: Chichester, UK 2004.
Rossouw JE, et al, Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomised controlled trial. JAMA 2002; 288: 321–333.
Weiss NS, Ure CL, Ballard JH, Williams AR, Daling JR . Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med 1980; 303: 1195–1198.
Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD . Postmenopausal hormone replacement therapy: scientific review. JAMA 2002; 288: 872–881.
Grodstein F, Newcomb PA, Stampfer MJ . Postmenopausal hormone replacement therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med 1999; 106: 574–582.
Henderson BE, Paganini-Hill A, Ross RK . Estrogen replacements therapy and protection from acute myocardial infarction. Am J Obstet Gynecol 1988; 159: 312–317.
Hunt K, Vessey M, McPherson K . Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis. Br J Obstet Gynaecol 1990; 97: 1080–1086.
Weiss NS . Health consequences of short- and long-term postmenopausal hormone therapy. Clin Chem 1996; 42 (8 Part 2): 1342–1344.
Grodstein F, Stampfer MJ, Falkeborn M, Naessen T, Persson I . Postmenopausal hormone therapy and risk of cardiovascular disease and hip fracture in a cohort of Swedish women. Epidemiology 1999; 10: 476–480.
Paganini-Hill A, Ross RK, Henderson BE . Postmenopausal oestrogen treatment and stroke: a prospective study. BMJ 1988; 297: 519–522.
Finucane FF, Madans JH, Bush TL, Wolf PH, Kleinman JC . Decreased risk of stroke among postmenopausal hormone users: results from a national cohort. Arch Intern Med 1993; 153: 73–79.
Falkeborn M, Persson L, Terent A, Adami HO, Lithell H, Bergstrom R . Hormone replacement therapy and the risk of stroke: follow-up of a population-based cohort in Sweden. Arch Intern Med 1993; 153: 1201–1209.
Hulley S et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998; 280: 605–613.
Grady D, et al, HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002; 288: 49–57.
Hippisley-Cox J, Pringle M, Crown N, Coupland C . A case–control study on the effect of hormone replacement therapy on ischaemic heart disease. Br J Gen Pract 2003; 53: 191–196.
Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S, Horwitz RI . A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med 2001; 345: 1243–1249.
Menson JE, et al, Women's Health Initiative Investigators. Estrogen plus progestin and the risk of coronary heart desease. N Engl J Med 2003; 349: 523–534.
Wassertheil-Smoller S, et al, WHI Investigators. Effects of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA 2003; 289: 2673–2684.
Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer. Lancet 1997; 350: 1047–1059.
Beral V, Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003; 362: 419–427.
Chlebowski RT, et al, WHI Investigators. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA 2003; 289: 3243–3253.
Holmberg L, Anderson H, HABITS steering and data monitoring committees. HABITS (hormonal replacement therapy after breast cancer-is it safe?), a randomised comparison: trial stopped. Lancet 2004; 363: 453–455.
Hoibraaten E, Qvigstad E, Arnesen H, Larsen S, Wickstrom E, Sandset PM . Increased risk of recurrent venous thromboembolism during hormone replacement therapy: results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET). Thromb Haemost 2000; 84: 961–967.
Miller J, Chan BKS, Nelson HD . Postmenopausal estrogen replacement and risk for venous thromboembolism: a systematic review and meta-analysis for the US Preventative Services Task Force. Ann Intern Med 2002; 136: 680–690.
Anderson GL, et al, Women's Health Initiative Investigators. Effects of estrogen plus progestin on gynecological cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial. JAMA 2003; 290: 1739–1748.
Shumaker SA, et al, WHIMS Investigators. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003; 289: 2651–2662.
Roberts D et al. Longitudinal study of bone turnover after acute spinal cord injury. J Clin Endorcinol Metab 1998; 83: 415–422.
Takata S, Yasui N . Disuse osteoporosis. J Med Invest 2001; 48: 147–156.
Biering-Sorensen F, Bohr H, Schaadt O . Bone mineral content of the lumbar spine and lower extremities years after spinal cord lesion. Paraplegia 1988; 26: 293–301.
Biering-Sorensen F, Bohr HH, Schaadt OP . Longitudinal study of bone mineral content in the lumbar spine, the forearm and the lower extremities after spinal cord injury. Eur J Clin Invest 1990; 20: 330–335.
Garland DE, Adkins RH, Stewart CA, Ashford R, Vigil D . Regional osteoporosis in women who have a complete spinal cord injury. J Bone Joint Surg Am 2001; 83-A: 1195–1200.
Garland DE et al. Osteoporosis after spinal cord injury. J Orthop Res 1992; 10: 371–378.
Szollar SM, Martin EM, Sartoris DJ, Parthemore JG, Deftos LJ . Bone mineral density and indexes of bone metabolism in spinal cord injury. Am J Phys Med Rehab 1998; 77: 28–35.
Ragnarsson KT, Sell GH . Lower extremity fractures after spinal cord injury: a retrospective study. Arch Phys Med Rehab 1981; 62: 418–423.
Nelson A, Ahmed S, Harrow J, Fitzgerald S, Sanchez-Anguiano A, Gavin-Dreschnack D . Fall-related fractures in persons with spinal cord impairment: a descriptive analysis. SCI Nurs 2003; 20: 30–37.
Savic G, Short DJ, Weitzenkamp D, Charlifue S, Gardner BP . Hospital readmissions in people with chronic spinal cord injury. Spinal Cord 2000; 38: 371–377.
Ott SM . Osteoporosis in women with spinal cord injuries. Phys Med Rehab Clin N Am 2001; 12: 111–131.
Weeks C . Women, spinal cord injury and osteoporosis. Top Spinal Cord Injury Rehab 2001; 7: 53–63.
Jackson AB . Menopausal issues after spinal cord injury. Top Spinal Cord Injury Rehab 2001; 7: 64–71.
Jackson AB, Wadley V . A multicenter study of women's self-reported reproductive health after spinal cord injury. Arch Phys Med Rehab 1999; 80: 1420–1428.
Maynard Jr FM et al. International standards for neurological and functional classification of spinal cord injury. Spinal Cord 1997; 35: 266–274.
Frankel HL et al. The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia. Paraplegia 1969; 7: 179–192.
Hope S . Key developments in women's health. Practitioner 1999; 243: 455–456, 459–461.
Haas JS, Kaplan CP, Gerstenberger EP, Kerlikowske K . Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann Intern Med 2004; 140: 184–188.
Ballard K . Women's use of hormone replacement therapy for disease prevention: results of a community survey. Br J Gen Pract 2002; 52: 835–857.
Hersh AL, Stefanick ML, Stafford RS . National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004; 291: 47–53.
Minelli C, Abrams KR, Sutton AJ, Cooper NJ . Benefits and harms associated with hormone replacement therapy: clinical decision analysis. BMJ 2004; 328: 371.
Kim C, Kwok YS . Decision analysis of hormone replacement therapy after the Women's Health Initiative. Am J Obstet Gynecol 2003; 189: 1228–1233.
Brennan K, Ayres J . The pros and cons of hormone replacement therapy. Nurs Times 2003; 99: 26–27.
Hays J, et al, Women's Health Initiative Investigators. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003; 348: 1839–1854.
Mullins CD, Ohsfeldt RL . Modeling of annual costs of postmenopausal prevention therapy: raloxifene, alendronate or estrogen-progestin therapy. J Manag Care Pharm 2003; 9: 150–158.
Torgerson DJ, Bell-Syer SE . Hormone replacement therapy and prevention of vertebral fractures: a meta-analysis of randomised trails. MBC Musculoskelet Disord 2001; 2: 7.
Barrett-Connor E et al. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study. Menopause 2003; 10: 412–419.
Cauley JA, et al, Women's Health Initiative Investigators. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA 2003; 290: 1729–1738.
Vestergaard P, Krogh K, Rejnmark L, Mosekilde L . Fracture rates and risk factors for fractures in patients with spinal cord injury. Spinal Cord 1998; 36: 790–796.
Stover SL, DeLisa JA, Whiteneck GG (eds). Spinal Cord Injury: Clinical Outcomes from the Model Systems. Aspen: Gaithensburg, MD 1995.
Frankel HL et al. Long-term survival in spinal cord injury: a fifty year investigation. Spinal Cord 1998; 36: 266–274.
Clinical Alert: NIH asks participants in Women's Health Initiative estrogen-alone study to stop study pills, begin follow-up phase, [online] 2004 [cited 02 March 2004]. Available from: URL:. http://www.nlm.nih.gov/databases/alerts/estrogen_alone.html.
Duff G . Further advice on safety of HRT: risk-benefit unfavourable for first-line use in prevention of osteoporosis, [online] 2003 [cited 03 December 2003]. Available from: URL:. http://medicines.mhra.gov.uk.
Deady J . Clinical monograph: hormone replacement therapy. J Manag Care Pharm 2004; 10: 33–47.
Shoemaker JR, Klemes AB . Alternate options to hormone replacement therapy for osteoporosis. J Am Osteopathol Assoc 2003; 103 (10 Suppl 6): S1–S5.
Ettinger MP . Aging bone and osteoporosis: strategies for preventing fractures in the elderly. Arch Intern Med 2003; 163: 2237–2246.
Reid IR . Pharmacotherapy of osteoporosis in postmenopausal women: focus on safety. Fxpert Opin Drug Safety 2002; 1: 93–107.
Martens MG . Risk of fracture and treatment to prevent osteoporosis-related fracture in postmenopausal women: a review. J Reprod Med 2003; 48: 425–434.
Wei GS, Jackson JL, Hatzigeorgiou C, Tofferi JK . Osteoporosis management in the new millennium. Prim Care 2003; 30: 711–741, vi–vii.
Watts NB . Bisphosphonate treatment of osteoporosis. Clin Geriatr 2003; 19: 395–414.
Fleisch H . Bisphosphonates in osteoporosis. Eur Spine 2003; 12 (Suppl 2): S142–S146.
Chappard D et al. Effects of tiludronate on bone loss in paraplegic patients. J Bone Miner Res 1995; 10: 112–118.
Pearson EG, Nance PW, Leslie WD, Ludwig S . Cyclical etidronate: its effect on bone density in patients with acute spinal cord injury. Arch Phys Med Rehab 1997; 78: 269–272.
Sniger W, Garshick E . Alendronate increases bone density in chronic spinal cord injury: a case report. Arch Phys Med Rehab 2002; 83: 139–140.
Reid IR et al. Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomised controlled trial. Am J Med 2000; 109: 362–370.
LaCroix AZ, Ott SM, Ichikawa L, Scholes D, Barlow WE . Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2000; 133: 516–526.
Hodsman AB et al. Efficacy and safety of human parathyroid hormone – (1–84) in increasing bone mineral density in postmenopausal osteoporosis. J Clin Endocrinol Metab 2003; 88: 5212–5220.
Debiais F . Efficacy data on teriparatide (parathyroid hormone) in patients with postmenopausal osteoporosis. Joint Bone Spine 2003; 70: 465–470.
Deal C . The use of intermittent human parathyroid hormone as a treatment for osteoporosis. Curr Rheumatol Rep 2004; 6: 49–58.
Simon JA, Mack CJ . Treatment of osteoporosis: combination therapies. Int J Fertil Womens Med 2003; 48: 127–131; discussion 137–138.
Black DM et al. PaTH Study Investigators. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 2003; 349: 1207–1215.
Kelley GA . Exercise and regional bone mineral density in postmenopausal women: a meta-analysis review of randomized trials. Am J Phys Med Rehab 1998; 77: 76–87.
Dauty M, Perrouin VB, Maugars Y, Dubois C, Mathe JF . Supralesional and sublesional bone mineral density in spinal cord-injured patients. Bone 2000; 27: 305–309.
Needham-Shropshire BM, Broton JG, Klose KJ, Lebwohl N, Guest RS, Jacobs PL . Evaluation of a training program for persons with SCI paraplegia using the Parastep 1 ambulation system: part 3. Lack of effect on bone mineral density. Arch Phys Med Rehab 1997; 78: 799–803.
BeDell KK, Scremin AM, Perell KL, Kunkel CF . Effects of functional electrical stimulation-induced lower extremity cycling on bone density of spinal cord-injured patients. Am J Phys Med Rehab 1996; 75: 29–34.
Eser P, de Bruin ED, Telley I, Lechner HE, Knecht H, Stussi E . Effects of electrical stimulation-induced cycling on bone mineral density in spinal cord-injured patients. Eur J Clin Invest 2003; 33: 412–419.
Jones LM, Legge M, Goulding A . Intensive exercise may preserve bone mass of the upper limbs in spinal cord injured males but does not retard demineralisation of the lower body. Spinal Cord 2002; 40: 230–235.
Mohr T, Podenphant J, Biering-Sorensen F, Galbo H, Thamsborg G, Kjaer M . Increased bone mineral density after prolonged electrically induced cycle training of paralysed limbs in spinal cord injured man. Calcif Tissue Int 1997; 61: 22–25.
Belanger M, Stein RB, Wheeler GD, Gordon T, Leduc B . Electrical stimulation: can it increase muscle strength and reverse osteopenia in spinal cord injured individuals? Arch Phys Med Rehab 2000; 81: 1090–1098.
Acknowledgements
The study was partly supported by the Stoke Mandeville Hospital Charitable Fund. The authors wish to thank the participants for taking part in the survey.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Khong, S., Savic, G., Gardner, B. et al. Hormone replacement therapy in women with spinal cord injury – a survey with literature review. Spinal Cord 43, 67–73 (2005). https://doi.org/10.1038/sj.sc.3101694
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.sc.3101694
